An UnrivaledSafety Profile12

An UnrivaledSafety Profile12

See Your Patient’s Safety

Sientra breast implants are clinically shown to have low complication rates1

A robust 10-year clinical study – the largest breast implant study of its kind – revealed unrivaled safety and clinical results12

1,788 patients enrolled   |   37 plastic surgery sites   |   evaluated for 10 years

1,788 patients enrolled

37 plastic surgery sites

evaluated for 10 years

Primary Augmentation Complication Rates1

%

Capsular Contracture III/IV

%

Rupture (MRI Cohort)

%

Reoperation

Key Complications Primary Augmentation (smooth and textured devices) Through 10 years, by Patient KM Risk Estimates

chart
Sientra Breast Augmentation Complication Rates Chart

Primary Reconstruction Complication Rates1, 12

%

Capsular Contracture III/IV

%

Rupture (MRI Cohort)

%

Reoperation

Key Complications Primary Reconstruction Cohort Through 10 years, by Patient KM Risk Estimates

chart
Sientra Breast Augmentation Complication Rates Chart

See Surgeon Exclusivity

Sientra is the ONLY major silicone gel breast implant manufacturer to sell exclusively to board-certified plastic surgeons. We believe this results in safer and more beautiful patient outcomes. Several key opinion leaders have recently expressed the importance of BCPS exclusivity:

I have greatly appreciated Sientra’s commitment to provide their product to board-certified plastic surgeons only. This decision clearly attests to their philosophy that patients are more important than profits and ensures that the best quality implants on the market are only available to those surgeons with the proper training to use them.

– ROB COHEN, BOARD-CERTIFIED PLASTIC SURGEON
Beverly Hills, CA

audrey-actual-patient-top
woman standing in doorway facing the viewer
connect with us
Scroll to top